Australian Red Cross Lifeblood

Site

Melbourne Processing Centre – Manufacturing

Accreditation No.

18808

Site No.

22664

Date of Accreditation

26 Jun 1985

Address

100 - 154 Batman Street
West Melbourne, VIC 3003
Australia

lifeblood.com.au

Contact

Ms A Chmiel P: +61 (03) 96940251

Availability

Services available to external clients

Supervision

Not Applicable

Scope of Accreditation

Print scopes
Melbourne Processing Centre – Manufacturing

ISO 15189 (2012)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Service Product Determinant
Requirements for information communication and reporting Not applicable NPAAC Requirements for Information Communication and Reporting
Testing – Donor Chemistry Testing

ISO 15189 (2012)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Service Product Determinant
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies Serum Ferritin
Testing – Infectious Disease Screening

ISO 15189 (2012)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Service Product Determinant
Microbiology - Bacteriology - Detection of pathogenic bacteria Plasma; Plasma derivatives; Platelet concentrates; Red cell concentrates; Serum Bacteria; Pathogenic microorganisms
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation Cadaveric blood Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Human T-lymphotropic virus type I/II (HTLV-I/II); Human immunodeficiency virus (HIV) p24 antigen; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Syphilis Treponema pallidum antibody
Plasma Plasmodium falciparum antibody; Plasmodium vivax antibody
Plasma; Serum Cytomegalovirus (CMV)
Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Human T-lymphotropic virus type I/II (HTLV-I/II); Human immunodeficiency virus (HIV) p24 antigen; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Syphilis Treponema pallidum antibody
Testing – Nucleic Acid Testing

ISO 15189 (2012)

Human Pathology

Service Product Determinant
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) Cadaveric donor Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA; Human immunodeficiency virus type 1 (HIV-1) RNA; Human immunodeficiency virus type 2 (HIV-2) RNA
Plasma Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA; Human immunodeficiency virus type 1 (HIV-1) RNA; Human immunodeficiency virus type 2 (HIV-2) RNA
Plasma; Serum Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA; Human immunodeficiency virus type 1 (HIV-1) RNA; Human immunodeficiency virus type 2 (HIV-2) RNA
Testing – Process Control

ISO 15189 (2012)

Human Pathology

Service Product Determinant
Haematology - Full blood examination Blood Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices
Testing – Red Cell Serology

ISO 15189 (2012)

Human Pathology

Service Product Determinant
Immunohaematology - Blood group antibody detection Blood; Plasma; Serum Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes
Immunohaematology - Blood grouping Blood; Plasma; Serum ABO; RhD
Immunohaematology - Identification and quantitation of blood group antibodies Blood; Plasma; Serum High titre anti-A and anti-B screening
Red blood cell phenotyping

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.